Novartis reports that Fabhalta® achieved the Phase III APPLAUSE-IgAN primary endpoint, showing slowed kidney-function decline ...
The global pharmaceutical drug delivery market is witnessing steady growth, driven by advancements in formulation ...
UK & Ireland is inviting laboratory equipment designers to its stand at the Lab Innovations exhibition to learn about the ...
BHL Removers will be eagerly awaiting conversation on stand D104 at Lab Innovations on 29 and 30 October at the NEC, ...
NEWARK, DELAWARE / ACCESS Newswire / October 23, 2025 / MedCognetics, a pioneer in artificial intelligence (AI) for breast cancer screening, has teamed up with Laurel Bridge Software, a leader in ...
NAPLES, FL / ACCESS Newswire / October 23, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell nutrition, is proud to announce a key strategic agreement to open a joint venture ...
SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2025 financial results that ...
New Florida stem cell law provides ZEO with new pathways to market and sell regenerative therapy products and advance clinical research initiatives FORT LAUDERDALE, FL / ACCESS Newswire / October 23, ...
With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management. ATLANTA, GA / ACCESS Newswire / October ...
Looking to connect with leading drug developers and discover next-generation therapeutics redefining neurodegenerative treatment? Look no further than the Alzheimer’s & Parkinson’s Drug Development ...
New findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer. MIAMI, FLORIDA / ...
LUND, SE / ACCESS Newswire / October 23, 2025 / Cantargia AB (publ) (Nasdaq Stockholm:CANTA)(STO:CANTA) today announced that management will participate in the following investor conferences.Stifel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results